Articles for the ‘’ Category

Amendment to the Act on Medicinal Products; new obligations to ensure availability of medicinal products

Published 24 January 2024 by Kateřina Slavíková HAVEL & PARTNERS | Czech Republic, Czech Republic

An amendment to the Act on Medicinal Products entered into effect as of 1 January 2024, imposing numerous new obligations on marketing authorisation holders, distributors and pharmacies, and expanding the existing powers of administrative authorities. The changes are primarily aimed at ensuring the availability of medicinal products for the needs of patients in the Czech Republic and increasing the resilience of the market to supply shortages of medicinal products.

... Read more